Re: Possible mold problem/sick toddler

[Guest guest]

I've been lurking around this site for many months and decided I needed to

respond straightaway to Connie. I have a very sick 4 1/2 year old son with mold

problems. He started getting sick and lagging developmentally at 16 months then

completely regressed and continued to get sicker while we went to specialist

after specialist. It wasn't until May 2005, nearly four years into his ordeal,

that he was diagnosed with mold problems and started on antifungal medication.

We saw geneticists, metabolic doctors, infectious disease, immunologists,

neurologists and gastroenterologists. He had CT scans, MRIs, spinal taps and

muscle biopsies. No one could figure out what was wrong. They told us to ''take

him home and hope for the best'' but that it didn't look good. They gave us

morphine to ''ease the transition'' and basically left us at a dead end. My

husband and I continued to research his illness and started going down the

candida/yeast track then got more deeply involved in the fungal-related illness.

We finally got hooked up with Dr. Marinkovich last May and he ran his bloodwork

and it was like a revelation.

My son is slowly overcoming his illness and getting stronger but it has taken a

long time and will continue to take a long time. He has to relearn

everything...sitting, walking, feeding himself. He met all those developmental

milestones then lost them because he was basically trying to stay alive for

three years.

So, the point here is...yes, it can affect children the same as adults. My son's

illness is severe because he went undiagnosed for so long. I'd love to speak

with you ''offline'' about this if you'd like.

By the way, my son also has numerous food sensitivities and struggles daily with

abdominal cramping and severe gas/indigestion. He cannot gain weight and hasn't

really grown in over three years. He just stopped everything to deal with the

illness.

Good luck and let me know if you'd like to talk,

[] Possible mold problem/sick toddler

I'm joining the group today, because I just noticed in the attic today

green mold on the rafters in our home. We don't have mold evidence

else where....but I know my son is allergic to mold also. His

environmental Dr. keeps thinking we have a mold problem that could be

affecting his development severely--but in door tests with petri dishes

didn't present anything a few months ago. He's had a cold for the last

17 days (congestion and cough) that doesn't go away...and now after

seeing the attic, I'm freaked to say the least.

No one else in the family appears to have problems. Logan is 2 years

old, and is still just learning to sit, with no medical tests ever

finding out what is wrong with him. He has severe food sensitivies,

allergies and cognitively is very delayed, as well as balance issues.

I'd love input from anyone that has knowledge about these kinds of

circumstances with kids/mold. And also, should I really be freaked out

at this time. At least it doesn't appear to be toxic black mold.

Connie

FAIR USE NOTICE:

[Guest guest]

Dr. Marinkovich ran bloodwork to test his antibody levels to 13 different

fungus; my son had high antibody levels to eight of them.

We tried HBOT with him as well and saw some benefit but he would plateau with

everything we tried..He would make a little progress then nothing. Even the

first antifungal medicine we tried (Nystatin) found him plateauing after about

five months. He now takes Econazole through Dr. Marinkovich and we just

increased that dose and have found he's going through another round of die-off

so its working but very slowly.

My son is 4 1/2 and only weighs 27 lbs..He is constantly hungry but we are

continually challenged about what to feed him that doesn't aggravate the fungus

and doesn't aggravate his food sensitivities. It seems like all foods fall into

one of the two categories for him.

Re: [] Possible mold problem/sick toddler

I found your story very interesting. Logan was developing normally until 4-6

months old, and has just gotten stuck developmentally until recently he has

started to sit for a few minutes at a time. We started HBOT and Vitamin B shots

which have helped. I found it very interesting what you say about the

antifungals, because Logan gets better ever time we take a round because of

yeast issues (from our environmental Dr.).....

We too have ran the gamet of specialist, to no avail. You mentioned Dr.

Marinkovich, is there a blood test that can tell if this is a toxic mold issue

that Logan has? What exactly is the blood test?

The food issues, and weight issues are identical to us plus he hasn't grown a

lot either. He is failure to thrive weight wise. He dropped off the chart a

few months ago because of lack of weight gain. He only weighs 23.5 pounds at 2

years 4 months. It's a struggle for sure.

Connie

[] Possible mold problem/sick toddler

I'm joining the group today, because I just noticed in the attic today

green mold on the rafters in our home. We don't have mold evidence

else where....but I know my son is allergic to mold also. His

environmental Dr. keeps thinking we have a mold problem that could be

affecting his development severely--but in door tests with petri dishes

didn't present anything a few months ago. He's had a cold for the last

17 days (congestion and cough) that doesn't go away...and now after

seeing the attic, I'm freaked to say the least.

No one else in the family appears to have problems. Logan is 2 years

old, and is still just learning to sit, with no medical tests ever

finding out what is wrong with him. He has severe food sensitivies,

allergies and cognitively is very delayed, as well as balance issues.

I'd love input from anyone that has knowledge about these kinds of

circumstances with kids/mold. And also, should I really be freaked out

at this time. At least it doesn't appear to be toxic black mold.

Connie

FAIR USE NOTICE:

[Guest guest]

meganreamer@a... wrote:

>

> Dr. Marinkovich ran bloodwork to test his antibody levels to 13

different fungus; my son had high antibody levels to eight of them.

>

> We tried HBOT with him as well and saw some benefit but he would

plateau with everything we tried..He would make a little progress

then nothing. Even the first antifungal medicine we tried (Nystatin)

found him plateauing after about five months. He now takes Econazole

through Dr. Marinkovich and we just increased that dose and have

found he's going through another round of die-off so its working but

very slowly.

>

Ask Dr Marinkovich about Vfend " Voriconazole " .

Interestingly enough, this article claims to be the first to compare

Vfend against Ampho-B / Fluconazole and yet Dr ph Heitman gave

me a straight across comparison when he was concluding phase 3

trials at Duke University five years ago and spoke very

enthusiastically about Vfend and low toxicity compared to Ampho B.

I asked Dr M to look into Vfend at the time and I wonder if he has

done it yet if his preferred therapy is Econazole.

-

Pfizer's Vfend equals two-drug candidemia regimen, with fewer

serious side effects, Lancet study

Category: Infectious Diseases/Bacteria/Viruses News

Article Date: 07 Nov 2005

Using Vfend® (voriconazole) for the treatment of nonneutropenic

patients with candidemia, an often-fatal hospital-acquired

bloodstream infection, is as effective as a regimen of two older

antifungals and carries fewer serious side effects than that

regimen. This is based on a study published in The Lancet in

October.

The study highlights Vfend, Pfizer's antifungal treatment, as an

important treatment option for candidemia in nonneutropenic patients

(those who do not have low white blood cell counts). Vfend is the

only treatment available in oral and IV formulations that is

approved as first-line therapy against both mould and yeast

infections.

" This study proves the effectiveness of Vfend for the treatment of

candidemia, an often-deadly fungal infection for which we need

multiple treatment options, " said Dr. Jack D. Sobel, study

investigator and professor and chief of the Division of Infectious

Diseases at Wayne State University School of Medicine. " Because of

Vfend's broad spectrum of activity against infections caused by

yeasts and moulds, it is a good first-choice treatment option for

immunocompromised patients who are at risk for those types of

infection. "

Candidemia is a systemic fungal infection in the blood that can lead

to other body organ infections. Surgical patients and patients with

compromised immune systems are at high risk for candidemia.

This study was the first ever to compare Vfend versus amphotericin B

followed by fluconazole, both of which are approved treatments for

candidemia. However, amphotericin B is commonly associated with

toxic effects, including a risk of kidney failure. In addition, the

prevalence of fluconazole-resistant Candida is increasing.

The study used a non-inferiority study design in which the trial

objective was to evaluate the comparability of differing treatment

options. Results showed that the treatment regimens were comparable

in terms of effectiveness, including time required to clear Candida

from the blood. Investigators concluded that Vfend is an effective

alternative to this regimen and that it is among the most useful

treatment options for candidemia in non-neutropenic patients due to

its efficacy, tolerability and broad spectrum, and also due to the

availability of IV and oral formulations.

Treatment discontinuations due to all-cause adverse events were more

frequent in the Vfend group, although most discontinuations in this

group were due to non-drug-related events. Patients taking Vfend

experienced fewer serious adverse events, such as renal toxicity.

Study details

The study included 370 patients who had at least one positive blood

culture for Candida within 96 hours of entering the study, and who

did not suffer from neutropenia. Patients were randomly assigned (in

a 2-to-1 ratio) to receive either Vfend or amphotericin B followed

by fluconazole.

In the Vfend group, patients received IV Vfend for three days

followed by oral Vfend for as long as needed, while the combination

group received IV amphotericin B for three to seven days followed by

oral fluconazole for as long as needed. Success was judged by

improved clinical signs and symptoms and a negative blood culture

for Candida 12 weeks after each patient's treatment ended.

In both treatment groups, 41 percent of patients reported a

successful response when assessed at 12 weeks after the end of

treatment. In the secondary analysis, which included all evaluable

patients, including those whose last assessment was sooner than 12

weeks, about two-thirds of patients in both groups reported success -

65 percent of Vfend patients and 71 percent of amphotericin

B/fluconazole patients, a difference that was not statistically

significant.

Treatment with Vfend was able to clear Candida from the blood as

quickly as amphotericin B plus fluconazole. The median time to

attain a negative blood culture was two days in both groups. The

adverse event rates were comparable between treatment groups.

However, significantly more serious adverse events (57 percent in

the amphotericin B/fluconazole group versus 46 percent in the Vfend

group) and cases of renal toxicity (21 percent for the amphotericin

B/fluconazole group versus 8 percent for the Vfend group) were

reported in the amphotericin B/fluconazole group.

There were more reports of visual events in the Vfend arm. The

mortality rate was similar at 42 percent for the amphotericin

B/fluconazole group and 36 percent for the Vfend group.

About Vfend

Vfend was discovered by Pfizer researchers and was developed to

address the unmet medical need for more effective and better-

tolerated options for patients at risk for serious fungal

infections. Vfend is currently approved in the United States for the

treatment of invasive aspergillosis, esophageal candidiasis,

candidemia in nonneutropenic patients (those without low white blood

cell counts) and certain Candida infections (disseminated infections

in skin and infections in abdomen, kidney, bladder wall and wounds).

Vfend is also approved as salvage therapy for fungal infections

caused by the pathogens Scedosporium apiospermum and Fusarium

species.

Vfend is the only IV/oral antifungal specifically indicated for the

first-line treatment of mould and yeast infections. The ability to

switch patients from IV to oral Vfend allows patients to remain on

the same medication throughout the course of treatment, on both an

inpatient and outpatient basis.

Most frequently reported adverse events (all causalities) in

therapeutic trials were visual disturbances, fever, rash, vomiting,

nausea, diarrhea, headache, sepsis, peripheral edema, abdominal pain

and respiratory disorder. Treatment-related adverse events that most

often led to discontinuation in clinical trials were elevated liver

function tests (LFTs), rash and visual disturbances. Vfend treatment-

related visual disturbances are common. The effect of Vfend on

visual function is not known if treatment continues beyond 28 days.

Vfend is contraindicated with terfenadine, astemizole, cisapride,

pimozide, quinidine (since increased plasma concentrations for these

drugs can lead to QT prolongation and rare occurrences of torsades

de pointes), sirolimus, rifampin, rifabutin, carbamazepine, long-

acting barbiturates, ergot alkaloids, efavirenz and ritonavir (400

mg q12h).

There have been uncommon cases of serious hepatic reactions during

treatment with Vfend (clinical hepatitis, cholestasis and fulminant

hepatic failure, including fatalities). LFTs should be evaluated at

the start of and during the course of therapy. Patients have rarely

developed serious cutaneous reactions, such as s-

syndrome, during treatment with Vfend.

Full prescribing information is available upon request or please

visit http://www.pfizer.com or http://www.vfend.com.

[Guest guest]

,

Thanks for the information...Should I assume by your last sentence that the

Econazole is not the best medicine available? Or that other therapies are

better/more potent? My son's GI symptoms are horrendous and he's had some relief

but not enough. He's also got abnormal proteins in his spinal fluid which we all

assume has interfered with his motor function...that and the mycotoxins.

Thanks,

[] Re: Possible mold problem/sick toddler

meganreamer@a... wrote:

>

> Dr. Marinkovich ran bloodwork to test his antibody levels to 13

different fungus; my son had high antibody levels to eight of them.

>

> We tried HBOT with him as well and saw some benefit but he would

plateau with everything we tried..He would make a little progress

then nothing. Even the first antifungal medicine we tried (Nystatin)

found him plateauing after about five months. He now takes Econazole

through Dr. Marinkovich and we just increased that dose and have

found he's going through another round of die-off so its working but

very slowly.

>

Ask Dr Marinkovich about Vfend " Voriconazole " .

Interestingly enough, this article claims to be the first to compare

Vfend against Ampho-B / Fluconazole and yet Dr ph Heitman gave

me a straight across comparison when he was concluding phase 3

trials at Duke University five years ago and spoke very

enthusiastically about Vfend and low toxicity compared to Ampho B.

I asked Dr M to look into Vfend at the time and I wonder if he has

done it yet if his preferred therapy is Econazole.

-

Pfizer's Vfend equals two-drug candidemia regimen, with fewer

serious side effects, Lancet study

Category: Infectious Diseases/Bacteria/Viruses News

Article Date: 07 Nov 2005

Using Vfend® (voriconazole) for the treatment of nonneutropenic

patients with candidemia, an often-fatal hospital-acquired

bloodstream infection, is as effective as a regimen of two older

antifungals and carries fewer serious side effects than that

regimen. This is based on a study published in The Lancet in

October.

The study highlights Vfend, Pfizer's antifungal treatment, as an

important treatment option for candidemia in nonneutropenic patients

(those who do not have low white blood cell counts). Vfend is the

only treatment available in oral and IV formulations that is

approved as first-line therapy against both mould and yeast

infections.

" This study proves the effectiveness of Vfend for the treatment of

candidemia, an often-deadly fungal infection for which we need

multiple treatment options, " said Dr. Jack D. Sobel, study

investigator and professor and chief of the Division of Infectious

Diseases at Wayne State University School of Medicine. " Because of

Vfend's broad spectrum of activity against infections caused by

yeasts and moulds, it is a good first-choice treatment option for

immunocompromised patients who are at risk for those types of

infection. "

Candidemia is a systemic fungal infection in the blood that can lead

to other body organ infections. Surgical patients and patients with

compromised immune systems are at high risk for candidemia.

This study was the first ever to compare Vfend versus amphotericin B

followed by fluconazole, both of which are approved treatments for

candidemia. However, amphotericin B is commonly associated with

toxic effects, including a risk of kidney failure. In addition, the

prevalence of fluconazole-resistant Candida is increasing.

The study used a non-inferiority study design in which the trial

objective was to evaluate the comparability of differing treatment

options. Results showed that the treatment regimens were comparable

in terms of effectiveness, including time required to clear Candida

from the blood. Investigators concluded that Vfend is an effective

alternative to this regimen and that it is among the most useful

treatment options for candidemia in non-neutropenic patients due to

its efficacy, tolerability and broad spectrum, and also due to the

availability of IV and oral formulations.

Treatment discontinuations due to all-cause adverse events were more

frequent in the Vfend group, although most discontinuations in this

group were due to non-drug-related events. Patients taking Vfend

experienced fewer serious adverse events, such as renal toxicity.

Study details

The study included 370 patients who had at least one positive blood

culture for Candida within 96 hours of entering the study, and who

did not suffer from neutropenia. Patients were randomly assigned (in

a 2-to-1 ratio) to receive either Vfend or amphotericin B followed

by fluconazole.

In the Vfend group, patients received IV Vfend for three days

followed by oral Vfend for as long as needed, while the combination

group received IV amphotericin B for three to seven days followed by

oral fluconazole for as long as needed. Success was judged by

improved clinical signs and symptoms and a negative blood culture

for Candida 12 weeks after each patient's treatment ended.

In both treatment groups, 41 percent of patients reported a

successful response when assessed at 12 weeks after the end of

treatment. In the secondary analysis, which included all evaluable

patients, including those whose last assessment was sooner than 12

weeks, about two-thirds of patients in both groups reported success -

65 percent of Vfend patients and 71 percent of amphotericin

B/fluconazole patients, a difference that was not statistically

significant.

Treatment with Vfend was able to clear Candida from the blood as

quickly as amphotericin B plus fluconazole. The median time to

attain a negative blood culture was two days in both groups. The

adverse event rates were comparable between treatment groups.

However, significantly more serious adverse events (57 percent in

the amphotericin B/fluconazole group versus 46 percent in the Vfend

group) and cases of renal toxicity (21 percent for the amphotericin

B/fluconazole group versus 8 percent for the Vfend group) were

reported in the amphotericin B/fluconazole group.

There were more reports of visual events in the Vfend arm. The

mortality rate was similar at 42 percent for the amphotericin

B/fluconazole group and 36 percent for the Vfend group.

About Vfend

Vfend was discovered by Pfizer researchers and was developed to

address the unmet medical need for more effective and better-

tolerated options for patients at risk for serious fungal

infections. Vfend is currently approved in the United States for the

treatment of invasive aspergillosis, esophageal candidiasis,

candidemia in nonneutropenic patients (those without low white blood

cell counts) and certain Candida infections (disseminated infections

in skin and infections in abdomen, kidney, bladder wall and wounds).

Vfend is also approved as salvage therapy for fungal infections

caused by the pathogens Scedosporium apiospermum and Fusarium

species.

Vfend is the only IV/oral antifungal specifically indicated for the

first-line treatment of mould and yeast infections. The ability to

switch patients from IV to oral Vfend allows patients to remain on

the same medication throughout the course of treatment, on both an

inpatient and outpatient basis.

Most frequently reported adverse events (all causalities) in

therapeutic trials were visual disturbances, fever, rash, vomiting,

nausea, diarrhea, headache, sepsis, peripheral edema, abdominal pain

and respiratory disorder. Treatment-related adverse events that most

often led to discontinuation in clinical trials were elevated liver

function tests (LFTs), rash and visual disturbances. Vfend treatment-

related visual disturbances are common. The effect of Vfend on

visual function is not known if treatment continues beyond 28 days.

Vfend is contraindicated with terfenadine, astemizole, cisapride,

pimozide, quinidine (since increased plasma concentrations for these

drugs can lead to QT prolongation and rare occurrences of torsades

de pointes), sirolimus, rifampin, rifabutin, carbamazepine, long-

acting barbiturates, ergot alkaloids, efavirenz and ritonavir (400

mg q12h).

There have been uncommon cases of serious hepatic reactions during

treatment with Vfend (clinical hepatitis, cholestasis and fulminant

hepatic failure, including fatalities). LFTs should be evaluated at

the start of and during the course of therapy. Patients have rarely

developed serious cutaneous reactions, such as s-

syndrome, during treatment with Vfend.

Full prescribing information is available upon request or please

visit http://www.pfizer.com or http://www.vfend.com.

FAIR USE NOTICE:

[Guest guest]

--- In , " Connie Bird " <conniebird@b...>

wrote:

>

> I found your story very interesting. Logan was developing normally

until 4-6 months old, and has just gotten stuck developmentally until

recently he has started to sit for a few minutes at a time. We

started HBOT and Vitamin B shots which have helped. I found it very

interesting what you say about the antifungals, because Logan gets

better ever time we take a round because of yeast issues (from our

environmental Dr.).....

Connie, I have five grown children and I can only imagine how you

must feel as a parent. I am on a CFS list which there has been a

retired PhD scientist on there for 7-8 years and trying to help us

solve this problem. He has attended several autism seminars and he

has come to the opinion that CFS and autism are almost the same, the

difference being when they get ill. CFS is after the brain has

developed. I hate to bring this up as you may have looked into

everything already but is it possbile that he is having problems from

the mercury which is in vaccines?

Bob

[Guest guest]

meganreamer@a... wrote:

> ,

> Thanks for the information...Should I assume by your last sentence

that the Econazole is not the best medicine available? Or that other

therapies are better/more potent? My son's GI symptoms are

horrendous and he's had some relief but not enough. He's also got

abnormal proteins in his spinal fluid which we all assume has

interfered with his motor function...that and the mycotoxins.

> Thanks,

>

Dr Heitman told me that Vfend was especially potent against

filamentous fungi and azole-resistant Candida species, to the point

of being equal to Amphotericin B, but without the liver toxicity.

He was really ecstatic about the results he was seeing in some very

serious infections.

Econazole has some serious limitations against certain Candida

species and I'm not sure that all doctors have discovered Vfend yet,

so I thought it might be worth asking.

Tested for Celiac Sprue - Gluten intolerance?

-

[Guest guest]

Connie,

If you don't mind me asking, what were some of your son's abnormal test results?

Did the doctors find anything wrong or was he labeled ''autistic'' as a

catch-all diagnosis?

I believe in the HBOT and we were doing it with my son as well...we actually

bought a chamber but we haven't used in a while. We were a little concerned that

we didn't have all the facts surrounding his parasites and whether some thrived

in aerobic environments and that we were really making things worse. I'm still

not clear on that issue but we'd like to start trying the HBOT again to repair

some tissue and cellular damage.

My son is definitely one step forward two steps back...he's got good days where

he's moving a lot and trying to talk and awful days where is belly is rock-hard

and he's whining and miserable. The good days are starting to outnumber the bad

but it's still up and down.

We started using a homeopathic growth hormone as well from Maxam Nutraceuticals

called Xomatropin. He's definitely much hungrier after he takes it so we're

keeping our fingers crossed.

Re: [] Possible mold problem/sick toddler

Thanks for you input. I definitly will be asking for a blood test today. I

have my son on allergy shots from Neutrilizing/Provocation testing which seems

to help some with the fussiness and the shiners under his eyes. We just started

HBOT and have already seen some progress. We have 40 in our first set, so I'm

hoping to at least get some improvements out of the first batch. His GI system

already seems to be a little better in the sense he isn't spitting up/vomiting

as much. He is more interested in toys and is sitting much better. This is

after 10, so I'll keep my fingers crossed, and pray we continue to see progress

and that we keep the progress.

At Logan's rate of weight gain I wouldn't be surprised if he ended up at your

sons weight at that age. I think this is the most frustrating part. Not to be

able to put weight on him. I just started homeopathich human growth hormone

from biomedcomm, I'll let you know if we see anything positive from it....it is

suppose to help with weight gain if given in small doses as in the homeopathic

formula. My enviro Dr. actually has dealt more with autistic children than

children like Logan with motor and autistic symptoms, so we are the first one of

his patients to use it, but he had talked with the Dr. that made it, and she

thought it would help. Let me know if you want more info.

Connie

[] Possible mold problem/sick toddler

I'm joining the group today, because I just noticed in the attic today

green mold on the rafters in our home. We don't have mold evidence

else where....but I know my son is allergic to mold also. His

environmental Dr. keeps thinking we have a mold problem that could be

affecting his development severely--but in door tests with petri dishes

didn't present anything a few months ago. He's had a cold for the last

17 days (congestion and cough) that doesn't go away...and now after

seeing the attic, I'm freaked to say the least.

No one else in the family appears to have problems. Logan is 2 years

old, and is still just learning to sit, with no medical tests ever

finding out what is wrong with him. He has severe food sensitivies,

allergies and cognitively is very delayed, as well as balance issues.

I'd love input from anyone that has knowledge about these kinds of

circumstances with kids/mold. And also, should I really be freaked out

at this time. At least it doesn't appear to be toxic black mold.

Connie

FAIR USE NOTICE:

[Guest guest]

Tested negative for Celiac and we even did the whole gluten-free diet with no

changes. We've been so sensitive to his GI issues (eating only organic, using

probiotics, allergy testing, etc..) that I'm surprised and, frankly, bewildered

about where to go next...With all the changes we've made, it seems like he

should be significantly better. That is one of the reasons we are trying to see

Dr. Shoemaker...we feel like it may be a toxin issue that he's not clearing

them; they just re-circulate throughout his bloodstream and continue the chronic

illness.

[] Re: Possible mold problem/sick toddler

meganreamer@a... wrote:

> ,

> Thanks for the information...Should I assume by your last sentence

that the Econazole is not the best medicine available? Or that other

therapies are better/more potent? My son's GI symptoms are

horrendous and he's had some relief but not enough. He's also got

abnormal proteins in his spinal fluid which we all assume has

interfered with his motor function...that and the mycotoxins.

> Thanks,

>

Dr Heitman told me that Vfend was especially potent against

filamentous fungi and azole-resistant Candida species, to the point

of being equal to Amphotericin B, but without the liver toxicity.

He was really ecstatic about the results he was seeing in some very

serious infections.

Econazole has some serious limitations against certain Candida

species and I'm not sure that all doctors have discovered Vfend yet,

so I thought it might be worth asking.

Tested for Celiac Sprue - Gluten intolerance?

-

FAIR USE NOTICE:

[Guest guest]

I found your story very interesting. Logan was developing normally until 4-6

months old, and has just gotten stuck developmentally until recently he has

started to sit for a few minutes at a time. We started HBOT and Vitamin B shots

which have helped. I found it very interesting what you say about the

antifungals, because Logan gets better ever time we take a round because of

yeast issues (from our environmental Dr.).....

We too have ran the gamet of specialist, to no avail. You mentioned Dr.

Marinkovich, is there a blood test that can tell if this is a toxic mold issue

that Logan has? What exactly is the blood test?

The food issues, and weight issues are identical to us plus he hasn't grown a

lot either. He is failure to thrive weight wise. He dropped off the chart a

few months ago because of lack of weight gain. He only weighs 23.5 pounds at 2

years 4 months. It's a struggle for sure.

Connie

[] Possible mold problem/sick toddler

I'm joining the group today, because I just noticed in the attic today

green mold on the rafters in our home. We don't have mold evidence

else where....but I know my son is allergic to mold also. His

environmental Dr. keeps thinking we have a mold problem that could be

affecting his development severely--but in door tests with petri dishes

didn't present anything a few months ago. He's had a cold for the last

17 days (congestion and cough) that doesn't go away...and now after

seeing the attic, I'm freaked to say the least.

No one else in the family appears to have problems. Logan is 2 years

old, and is still just learning to sit, with no medical tests ever

finding out what is wrong with him. He has severe food sensitivies,

allergies and cognitively is very delayed, as well as balance issues.

I'd love input from anyone that has knowledge about these kinds of

circumstances with kids/mold. And also, should I really be freaked out

at this time. At least it doesn't appear to be toxic black mold.

Connie

FAIR USE NOTICE:

[Guest guest]

Thanks for you input. I definitly will be asking for a blood test today. I

have my son on allergy shots from Neutrilizing/Provocation testing which seems

to help some with the fussiness and the shiners under his eyes. We just started

HBOT and have already seen some progress. We have 40 in our first set, so I'm

hoping to at least get some improvements out of the first batch. His GI system

already seems to be a little better in the sense he isn't spitting up/vomiting

as much. He is more interested in toys and is sitting much better. This is

after 10, so I'll keep my fingers crossed, and pray we continue to see progress

and that we keep the progress.

At Logan's rate of weight gain I wouldn't be surprised if he ended up at your

sons weight at that age. I think this is the most frustrating part. Not to be

able to put weight on him. I just started homeopathich human growth hormone

from biomedcomm, I'll let you know if we see anything positive from it....it is

suppose to help with weight gain if given in small doses as in the homeopathic

formula. My enviro Dr. actually has dealt more with autistic children than

children like Logan with motor and autistic symptoms, so we are the first one of

his patients to use it, but he had talked with the Dr. that made it, and she

thought it would help. Let me know if you want more info.

Connie

[] Possible mold problem/sick toddler

I'm joining the group today, because I just noticed in the attic today

green mold on the rafters in our home. We don't have mold evidence

else where....but I know my son is allergic to mold also. His

environmental Dr. keeps thinking we have a mold problem that could be

affecting his development severely--but in door tests with petri dishes

didn't present anything a few months ago. He's had a cold for the last

17 days (congestion and cough) that doesn't go away...and now after

seeing the attic, I'm freaked to say the least.

No one else in the family appears to have problems. Logan is 2 years

old, and is still just learning to sit, with no medical tests ever

finding out what is wrong with him. He has severe food sensitivies,

allergies and cognitively is very delayed, as well as balance issues.

I'd love input from anyone that has knowledge about these kinds of

circumstances with kids/mold. And also, should I really be freaked out

at this time. At least it doesn't appear to be toxic black mold.

Connie

FAIR USE NOTICE: